Deal Ideation and Sourcing

Identify and prioritise in-licensing out-licensing and co-development prospects across complex generics injectables inhalation ophthalmics transdermals long-acting formulations drug device combinations and biosimilars Maintain a live opportunity map by molecule dosage form territory and therapeutic area covering patent and exclusivity timelines expected entrants and likely competitive intensity Generate leads from a cold start rather than relying on inbound flow track pipeline disclosures regulatory filings litigation dockets conference activity and industry press to spot openings early Bring forward differentiated theses including unconventional deal shapes and partner pairingsAnalysis and Business Case

Build market models covering sizing price erosion share capture cost of goods development spend and launch timing Run valuation and economics NPV IRR milestone and royalty design profit-share and transfer-price mechanics upfront versus back-loaded trade-offs Pressure-test assumptions with R D regulatory affairs manufacturing supply chain quality finance and the in-market teams before recommendations advance Prepare and present decision-ready material for senior management and investment committeesNetwork Building and Partner Engagement

Cultivate a durable external network across originators generics and biosimilar developers CDMOs API suppliers distributors licensing agents and advisors with particular depth in both home regions Represent Lotus at partnering meetings industry conferences and one-to-one discussions CPHI DCAT etc Serve as a persuasive external face for the company explaining Lotus s capabilities technical strengths and partnering interests without ambiguity Keep structured intelligence on counterparty strategy capabilities and past behaviour at the negotiating tableExecution and Contracting





Lead or support negotiation of term sheets LOIs MOUs and definitive agreements spanning licence supply development and co-development documents Coordinate due diligence across technical regulatory IP quality and market workstreams manage findings and their bearing on terms Collaborate with Legal and IP to translate intent into workable language and to surface risk early Depending on transaction scale and your seniority either own a negotiation end to end or run defined workstreams inside a larger teamAlliance Management Support

Assist Alliance Management on demanding partnerships governance set-up joint steering committees KPI tracking and issue escalation Provide continuity between signature and execution so the reasoning behind negotiated terms reaches the people delivering against it Contribute to amendments scope expansions and renegotiations as programmes evolveInternal Collaboration

Align sourcing priorities with colleagues running the American and Asian businesses Keep pipeline reporting and CRM records current giving leadership an accurate view of stage probability and expected value Feed into portfolio strategy and long-range planningMinimum 5–8 years in the pharmaceutical industry, concentrated on generics and biosimilars. Candidates at the upper end of that range, or with wider transaction ownership, will be considered at Senior Manager level.Prior business development experience is non-negotiable. This role is not an entry point into the function from an adjacent discipline.A record built at reputed pharmaceutical organisations and/or entrepreneurial firms where individual ownership ran high and support functions stayed lean.Demonstrable involvement in completed transactions — licensing, supply, co-development or M&A-adjacent; — with a specific account of what you personally contributed.Familiarity with the US landscape (ANDA, 505(b)(2), 351(k) pathways, Paragraph IV litigation, distribution channels and pricing) and with Asian development and manufacturing ecosystems.

#J-18808-Ljbffr

📌 Business Development Manager / Senior Manager (Madrid)
🏢 Confidential
📍 Madrid